CMS2 is driven by WNT and MYC pathway activation and is often associated with high chromosomal instability (CIN), while CMS3 exhibits metabolic reprogramming and frequent KRAS/PI3K mutations. Here, MYC is linked to cervical squamous intraepithelial neoplasia.